Project Grant HT94252510143
Award Date
8/1/25
Completion Date
7/31/29
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60637, USA
Similar Awards
The University of Chicago will receive $2,624,000 through a Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to investigate the role of amino acid metabolism in pulmonary fibrosis. Through this award, the University of Chicago aims to advance understanding of medical solutions for pulmonary disorders and translate findings into improved patient...
This federal Project Grant award of $820,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) was provided to the University of Chicago to conduct research on "Determining and Exploiting Metabolic Vulnerabilities of Cancer-Associated Fibroblast Heterogeneity." The research project aims to explore metabolic differences within cancer-associated fibroblasts and leverage those findings to develop new therapeutic approaches. The...
This $1,306,778 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research initiatives at the University of Chicago focused on immunologic drivers of lineage bias in TP53-mutant acute leukemia. The research aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis, treatment, and...
This federal Project Grant award, valued at $869,193.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research at the University of Chicago to identify the pathogenesis of monosomy 7 in bone marrow failure (BMF). The 3-year award, effective July 1, 2025 through June 30, 2028, will fund advanced scientific investigations to advance the understanding of this genetic disorder and its impacts on hematopoietic...
The University of Chicago will receive $1,229,184 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) from July 1, 2022 to June 30, 2025. The funding will support research into microRNA-mediated regulation of prostate cancer biology. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions for battlefield medicine. The University of...
The University of Chicago was awarded a $2,624,000.00 Project Grant from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to fund the research project "TARGETING TISSUE-RESIDENT ALVEOLAR MACROPHAGE METABOLISM IN ACUTE LUNG INJURY". This four-year grant, running from April 1, 2024 to March 31, 2028, supports cutting-edge biomedical research aimed at improving health outcomes for military service members, veterans, and their families. The research...
This federal Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), provides $3,085,852.00 to the University of Chicago to develop novel claudin-2 channel blockers for the treatment of inflammatory bowel disease. The 4-year project, starting on Jul 1, 2024 and ending on Jun 30, 2028, aims to advance the research and development of new therapeutic approaches for this debilitating condition. As a leading...
This federal Project Grant award of $1,612,104.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Chicago to develop senescent tumor cell-loaded dendritic cell vaccines for breast cancer. The research aims to transform healthcare for military service members and the broader public by advancing innovative approaches to disease prevention, diagnosis, and treatment. The award,...
The University of Chicago was awarded a $574,000 Project Grant from the Defense Health Agency to support a research project titled "A HUMAN PLURIPOTENT STEM CELL-BASED APPROACH TO IDENTIFYING THE DRIVERS OF PULMONARY CARCINOID". The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on transforming health care for service members and the public through innovative biomedical research. The project, spanning from September 1, 2023 to...
The University of Chicago was awarded a $1,032,525 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support the development of digital pathology biomarkers for breast cancer recurrence scoring through September 2025. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will further...